Skip to main content

View full-text article in PMC

. 2024 Nov 4;19:153. doi: 10.1186/s13020-024-01025-6

Table 5.

The comparison of safety indicators before and after treatment in two groups

Group/indicator	Baseline	Chemo#1	P value	Chemo#2	P value
SXD group
ALT(IU/L)	28.34 ± 23.28	28.68 ± 41.93	0.431^a	25.55 ± 18.73	0.6669^a
AST(IU/L)	24.55 ± 14.74	21.34 ± 9.83	0.0133^a	20.91 ± 7.95	0.1047^a
Urea(mmol/L)	4.89 ± 1.63	5.49 ± 2.93	0.4248^a	5.21 ± 1.99	0.3835^a
CR(μmol/L)	63.73 ± 14.69	65.32 ± 17.12	0.1252^a	62.58 ± 15.04	0.5677^a
D-D(mg/L)	0.83 ± 0.97	0.91 ± 1.08	0.0063^a	0.84 ± 1.06	0.9945^a
Placebo group
ALT(IU/L)	22.95 ± 19.31	22.07 ± 20.32	0.9227^a	20.30 ± 16.06	0.8679^a
AST(IU/L)	21.66 ± 10.63	20.28 ± 9.25	0.3717^a	19.69 ± 10.03	0.2507^a
Urea(mmol/L)	10.82 ± 41.95	5.30 ± 1.76	0.6439^a	5.49 ± 2.74	0.4867^a
CR(μmol/L)	64.32 ± 12.81	64.12 ± 14.35	0.8639^b	67.24 ± 21.45	0.8027^a
D-D(mg/L)	1.25 ± 1.53	1.26 ± 1.42	0.8298^a	1.39 ± 3.21	0.4952^a

^aWilcoxon rank sum test

^bt -test